UIVAX Mutual Fund

UIVAX Mutual Fund

NAV$22.40
See how much of UIVAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$610M
Expense Ratio
0.89%
Dividend Yield (Current)
1.13%
Holdings
211
Inception Date
Aug 1, 2008
Fund Family
Victory Capital Management Inc.
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
SEC 30-Day Yield
PRO

Performance

YTD+11.13%
1 Year+16.85%
3 Year+18.28%
5 Year+11.84%
10 Year+10.98%

Asset Allocation

Stocks: 99.71%
Bonds: 0.29%
See how much of UIVAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
AMZNAmazon.Com Inc4.51%
AAPLApple, Inc3.85%
MSFTMicrosoft Corp3.44%
JPMJpmorgan Chase2.65%
JNJJohnson & Johnson - Common1.49%
Top 10 Concentration: 22.57%Report Date: Jul 31, 2026
Download all 211 holdings for UIVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.13%
Latest Distribution
$0.26
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

UIVAX Mutual Fund Overview

UIVAX Mutual Fund (Victory Value Fund Institutional Class) is managed by Victory Capital Management Inc. with $609.5M in net assets. UIVAX expense ratio is 0.89%, holding 211 positions across sectors including Information Technology, Financials, Health Care. Inception date: 2008-08-01.

UIVAX performance shows a YTD return of 11.13%. The 1-year return is 16.85% and the 5-year return is 11.84%. UIVAX dividend yield stands at 1.13%.

UIVAX top holdings include Amazon.Com Inc (4.5%), Apple, Inc (3.9%), Microsoft Corp (3.4%), Jpmorgan Chase (2.6%), Johnson & Johnson - Common (1.5%). Go to all UIVAX holdings, UIVAX sectors, or UIVAX dividends.

UIVAX can be compared against other funds. Use UIVAX overlap to find shared positions, or UIVAX vs another fund for a side-by-side view. UIVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.